Abstract
As most efforts in the last decade have focused on the immunologic basis of inflammatory skin disease, there has been less emphasis on the role of the nervous system in the disease process of psoriasis. Evidence in support of the neurocutaneous pathway has come from observations of patients experiencing unilateral improvement and even complete remission following nerve damage in the affected dermatomal region. The aim of this review was to investigate the role of neuropeptides in the intricate pathophysiology of psoriasis. The PubMed database was searched for individual case reports or case series that reported clearance or significant improvement in psoriatic disease in patients following documented nerve injury. A total of 11 cases were found that reported improvement of psoriatic lesions in areas afflicted by central or peripheral nerve injury. The most common causes of denervation were inadvertent surgical interruption, cerebrovascular accident, and poliomyelitis. In four cases the patients eventually regained neurologic function, which was associated with a recurrence of skin lesions. In cases of permanent nerve damage, there was remission of psoriasis. The cases reported in the literature to date provide clinical evidence that absence of neural input leads to psoriasis improvement, suggesting a crucial role of the nervous system in the pathophysiology of psoriatic disease. In fact, neuropeptides such as nerve growth factor, substance P, calcitonin gene-related peptide, and vasoactive intestinal peptide may be important contributors of psoriatic disease and potential targets for future therapies.
Similar content being viewed by others
References
Boehncke W-HH, Schön MP. Psoriasis. Lancet. 2015;386(9997):983–94.
Di Cesare A, Di Meglio P, Nestle FO. The IL-23/Th17 axis in the immunopathogenesis of psoriasis. J Invest Dermatol. 2009;129(6):1339–50.
Dewing SB. Remission of psoriasis associated with cutaneous nerve section. Arch Dermatol. 1971;104(2):220.
Weiner S, Bassett L, Reichman R. Protective effect of poliomyelitis on psoriatic arthritis. Arthritis Rheum. 1985;28(6):703–6.
Farber EM, Lanigan SW, Boer J. The role of cutaneous sensory nerves in the maintenance of psoriasis. Int J Dermatol. 1990;29(6):418–20.
Raychaudhuri S, Farber E. Are sensory nerves essential for the development of psoriatic lesions? J Am Acad Dermatol. 1993;28(3):488–9.
Joseph T, Kurian J, Warwick DJ, Friedmann PS. Unilateral remission of psoriasis following traumatic nerve palsy. Br J Dermatology. 2005;152(1):185–6.
Kane D, Lockhart J, Balint P, Mann C, Ferrell W, McInnes I. Protective effect of sensory denervation in inflammatory arthritis (evidence of regulatory neuroimmune pathways in the arthritic joint). Ann Rheum Dis. 2005;64(2):325–7.
Ravikumar B, Sinhasan. Psoriasis sparing the polio-affected limb: is it merely the Koebner phenomenon? Indian J Dermatol. 2014;59(5):505–6.
Wang TS, Tsai TF. Psoriasis sparing the lower limb with postpoliomyelitis residual paralysis. Br J Dermatol. 2014;171(2):429–31.
Veale, Farrell, Fitzgerald. Mechanism of joint sparing in a patient with unilateral psoriatic arthritis and a longstanding hemiplegia. Br J Rheumatol. 1993;32(5):413–6.
Sowell J, Peppenger M, Crowe M. Psoriasis contralateral to hemiparesis following cerebrovascular accident. Int J Dermatol. 1993;32(8):598–9.
Stratigos AJ, Katoulis AK, Stavrianeas NG. Spontaneous clearing of psoriasis after stroke. J Am Acad Dermatol. 1998;38(5 Pt 1):768–70.
Weddell G, Cowan MA, Palmer E, Ramaswamy S. Psoriatic skin. Arch Dermatol. 1965;91:252–66.
Darsow U, Ring J. Neuroimmune interactions in the skin. Curr Opin Allergy Clin Immunol. 2001;1(5):435–9.
Nakamura M, Toyoda M, Morohashi M. Pruritogenic mediators in psoriasis vulgaris: comparative evaluation of itch-associated cutaneous factors. Br J Dermatol. 2003;149(4):718–30.
Kumar B, Raychaudhuri SP, Vossough S, Farber E. The rare coexistence of leprosy and psoriasis. Int J Dermatol. 1992;31(8):551–4.
Kiil J. Surgical treatment of psoriasis. Lancet. 1985;326(8445):16–8.
Elberg JJ, Brandrup F. Dermatome shaving of psoriasis. Br J Dermatol. 1987;117(6):745–50.
Ostrowski S, Belkadi A, Loyd C, Diaconu D, Ward N. Cutaneous denervation of psoriasiform mouse skin improves acanthosis and inflammation in a sensory neuropeptide-dependent manner. J Investig Dermatol. 2011;131(7):1530–8.
Raychaudhuri S, Raychaudhuri S. Role of NGF and neurogenic inflammation in the pathogenesis of psoriasis. Prog Brain Res. 2004;146:433–7.
Scholzen T, Armstrong CA, Bunnett NW, Luger TA, Olerud JE, Ansel JC. Neuropeptides in the skin: interactions between the neuroendocrine and the skin immune systems. Exp Dermatol. 1998;7(2–3):81–96.
Glinski W, Brodecka H, Glinska-Ferenz M, Kowalski D. Neuropeptides in psoriasis: possible role of beta-endorphin in the pathomechanism of the disease. Int J Dermatol. 1994;33(5):356–60.
Raychaudhuri SP, Farber EM. Neuroimmunologic aspects of psoriasis. Cutis. 2000;66(5):357–62.
Luger TA, Lotti T. Neuropeptides: role in inflammatory skin diseases. J Eur Acad Dermatol Venereol. 1998;10(3):207–11.
Raychaudhuri S, Jiang W-Y, Raychaudhuri S. Revisiting the Koebner phenomenon role of NGF and its receptor system in the pathogenesis of psoriasis. Am J Pathol. 2008;172(4):961–71.
Pincelli C. Nerve growth factor and keratinocytes: a role in psoriasis. Eur J Dermatol. 2000;10(2):85–90.
Fantini F, Magnoni C, Bracci-Laudiero L, TE Pincelli C. Nerve growth factor is increased in psoriatic skin. J Invest Dermatol. 1995;105(6):854–5.
Raychaudhuri S, Jiang W, Farber E. Psoriatic keratinocytes express high levels of nerve growth factor. Acta Dermato-Venereol. 1998;78(2):84–6.
Kanda N, Watanabe S. Histamine enhances the production of nerve growth factor in human keratinocytes. J Investig Dermatol. 2003;121(3):570–7.
Farber Nickoloff, Recht Fraki. Stress, symmetry, and psoriasis: possible role of neuropeptides. J Am Acad Dermatol. 1986;14(2 Pt 1):305–11.
Riol-Blanco L, Ordovas-Montanes J, Perro M, et al. Nociceptive sensory neurons drive interleukin-23-mediated psoriasiform skin inflammation. Nat. 2014;510(7503):157–61.
Bernstein JE, Parish LC, Rapaport M, Rosenbaum MM, Roenigk HH. Effects of topically applied capsaicin on moderate and severe psoriasis vulgaris. J Am Acad Dermatol. 1986;15(3):504–7.
Perlman HH. Remission of psoriasis vulgaris from the use of nerve-blocking agents. Arch Dermatol. 1972;105(1):128–9.
Roblin D, Yosipovitch G, Boyce B, et al. Topical TrkA kinase inhibitor CT327 is an effective, novel therapy for the treatment of pruritus due to psoriasis: results from experimental studies, and efficacy and safety of CT327 in a phase 2b clinical trial in patients with psoriasis. Acta Derm Venereol. 2015;95(5):542–8.
Peters E, Liezmann C, Klapp B, Kruse J. The neuroimmune connection interferes with tissue regeneration and chronic inflammatory disease in the skin. Ann York Acad Sci. 2012;1262(1):118–26.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
No funding was provided for this review.
Conflict of interest
Dr. Koo is an advisor, a consultant, and involved with speakers bureaus for AbbVie, Janssen, LEO, Photomedex, Amgen, AstraZeneca, Merck, Sun Pharmaceutical Industries, Novartis, and Pfizer. Mr. Zhu, Dr. Nakamura, Mr. Abrouk, Mr. Farahnik, Ms. Lee, Ms. Singh, Dr. Gevorgyan, and Dr. Bhutani have no conflicts of interest to declare.
Rights and permissions
About this article
Cite this article
Zhu, T.H., Nakamura, M., Farahnik, B. et al. The Role of the Nervous System in the Pathophysiology of Psoriasis: A Review of Cases of Psoriasis Remission or Improvement Following Denervation Injury. Am J Clin Dermatol 17, 257–263 (2016). https://doi.org/10.1007/s40257-016-0183-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40257-016-0183-7